Trade Travere Therapeutics, Inc. - TVTX CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.09 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023624% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001401% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 17.89 |
| Open | 16.94 |
| 1-Year Change | 141.31% |
| Day's Range | 15.95 - 16.94 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 2, 2025 | 17.89 | 0.86 | 5.05% | 17.03 | 18.06 | 17.03 |
| Apr 1, 2025 | 17.39 | -0.50 | -2.79% | 17.89 | 18.84 | 17.31 |
| Mar 31, 2025 | 17.87 | -1.14 | -6.00% | 19.01 | 19.21 | 17.40 |
| Mar 28, 2025 | 19.63 | -0.61 | -3.01% | 20.24 | 20.36 | 19.42 |
| Mar 27, 2025 | 20.33 | -0.22 | -1.07% | 20.55 | 21.09 | 20.30 |
| Mar 26, 2025 | 20.75 | -0.17 | -0.81% | 20.92 | 21.20 | 20.31 |
| Mar 25, 2025 | 20.98 | -0.07 | -0.33% | 21.05 | 21.20 | 20.64 |
| Mar 24, 2025 | 21.23 | 0.46 | 2.21% | 20.77 | 21.29 | 20.44 |
| Mar 21, 2025 | 20.44 | -0.09 | -0.44% | 20.53 | 20.77 | 20.18 |
| Mar 20, 2025 | 20.80 | 0.39 | 1.91% | 20.41 | 20.94 | 20.39 |
| Mar 19, 2025 | 20.66 | 1.13 | 5.79% | 19.53 | 20.69 | 19.52 |
| Mar 18, 2025 | 19.79 | -0.70 | -3.42% | 20.49 | 20.52 | 19.77 |
| Mar 17, 2025 | 20.83 | 0.79 | 3.94% | 20.04 | 20.96 | 19.96 |
| Mar 14, 2025 | 19.68 | 0.86 | 4.57% | 18.82 | 19.77 | 18.68 |
| Mar 13, 2025 | 19.09 | 0.46 | 2.47% | 18.63 | 19.56 | 18.63 |
| Mar 12, 2025 | 19.23 | 1.15 | 6.36% | 18.08 | 19.55 | 18.08 |
| Mar 11, 2025 | 18.08 | 0.36 | 2.03% | 17.72 | 18.64 | 17.67 |
| Mar 10, 2025 | 17.82 | 0.20 | 1.14% | 17.62 | 18.05 | 17.11 |
| Mar 7, 2025 | 18.05 | -0.70 | -3.73% | 18.75 | 19.23 | 18.01 |
| Mar 6, 2025 | 18.90 | 0.07 | 0.37% | 18.83 | 19.37 | 18.60 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Travere Therapeutics, Inc. Company profile
Travere Therapeutics (TVTX) is a US-based biopharmaceutical company that identifies, develops and delivers life-changing therapies to people suffering from rare diseases. The firm is headquartered in San Diego, California.
The company currently has four approved commercial therapies: Chenodal (chenodiol), Cholbam (cholic acid), Thiola (tiopronin), and Thiola EC (tiopronin) delayed-release tablets.
The rare diseases for which the company currently offers therapies are Peroxisomal Biogenesis Disorder-Zellweger Spectrum Disorder (PBD-ZSD), Cerebrotendinous Xanthomatosis (CTX), Focal Segmental Glomerulosclerosis (FSGS), IgA Nephropathy (IgAN), Classical Homocystinuria (HCU), Cystinuria, Bile Acid Synthesis Disorders (BASD), N-Glycanase 1 (NGLY1) Deficiency, and Alagille Syndrome (ALGS).
Travere Therapeutics shares trade on the NASDAQ Stock Exchange under the ticker symbol TVTX. The company was founded as Retrophin Inc. in February 2011 and became public in December 2012.As of August 2022, Travere Therapeutics does not pay a dividend.
You can follow the ups and downs of the Travere Therapeutics stock price at Capital.com. Always stay on top of the latest price developments with our live TVTX stock price chart.
| Industry: | Bio Therapeutic Drugs |
3611 Valley Centre Dr
Suite 300
SAN DIEGO
CALIFORNIA 92130
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com